[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634936":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":10,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":31,"acronym":10,"eligibilityCriteria":32,"healthyVolunteers":33,"sex":34,"minAge":35,"maxAge":10,"enrollmentInfo":36,"targetDuration":10,"studyType":39,"phases":10,"briefSummary":40,"conditions":41,"keywords":10,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Hyperlipidemia",null,[12],"Diagnostic Test: Lipid Abnormality Mass Spectrometry Screening Model",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","Lipid Abnormality Mass Spectrometry Screening Model","By analyzing the lipid profile in human breath, explore a simple, fast, and non-invasive method for screening dyslipidemia",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Yan Yan","CONTACT","+861064456782","eva3321@sina.com",{"type":26,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100634936","development-and-clinical-validation-of-key-technologies-for-non-invasive-breath-metabolic-fingerprinting-for-large-scale-population-lipid-screening-100634936",false,"NCT07546162","Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. Voluntarily sign the informed consent form\n\nExclusion Criteria:\n\n1. Patients with lung cancer, asthma, chronic obstructive pulmonary disease, cystic fibrosis, or acute respiratory distress syndrome\n2. Women during pregnancy or breastfeeding\n3. Patients with chronic kidney disease (GFR \\\u003C60 ml\u002Fmin) or liver cirrhosis\n4. Individuals unable to cooperate in collecting exhaled breath samples",true,"ALL","18 Years",{"count":37,"type":38},280,"ESTIMATED","OBSERVATIONAL","This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.",[9],"NOT_YET_RECRUITING","2026-04-20",{"date":45,"type":46},"2026-04-22","ACTUAL",{"date":48,"type":38},"2026-04-02",{"date":50,"type":38},"2026-05-31",{"name":5,"class":6}]